Volume 49, Issue 44 pp. 8214-8219
Communication

Intracellular pH-Responsive Mesoporous Silica Nanoparticles for the Controlled Release of Anticancer Chemotherapeutics

Dr. Chia-Hung Lee

Dr. Chia-Hung Lee

Center for Nanomedicine Research, National Health Research Institutes, Zhunan, Miaoli 350 (Taiwan)

These authors contributed equally to this work.

Search for more papers by this author
Shih-Hsun Cheng

Shih-Hsun Cheng

Division of Medical Engineering Research, National Health Research Institutes, Zhunan Miaoli 350 (Taiwan), Fax: (+886) 37-586-440

Institute of NanoEngineering and MicroSystems, National Tsing Hua University, Hsinchu 300 (Taiwan)

These authors contributed equally to this work.

Search for more papers by this author
I-Ping Huang

I-Ping Huang

Division of Medical Engineering Research, National Health Research Institutes, Zhunan Miaoli 350 (Taiwan), Fax: (+886) 37-586-440

Search for more papers by this author
Dr. Jeffrey S. Souris

Dr. Jeffrey S. Souris

Department of Radiology, The University of Chicago, Chicago, IL 60637 (USA)

Search for more papers by this author
Prof. Chung-Shi Yang

Prof. Chung-Shi Yang

Center for Nanomedicine Research, National Health Research Institutes, Zhunan, Miaoli 350 (Taiwan)

Search for more papers by this author
Prof. Chung-Yuan Mou

Prof. Chung-Yuan Mou

Department of Chemistry, National Taiwan University, Taipei 106 (Taiwan)

Search for more papers by this author
Prof. Leu-Wei Lo

Prof. Leu-Wei Lo

Division of Medical Engineering Research, National Health Research Institutes, Zhunan Miaoli 350 (Taiwan), Fax: (+886) 37-586-440

Search for more papers by this author
First published: 23 September 2010
Citations: 293

This study was supported by the Grants MED-098-PP-04 and NM-098-PP-01 from the National Health Research Institutes of Taiwan; and NSC 098-2221-E-400-001 from the National Science Council of Taiwan. We thank Yu-Ching Chen, Chia-Hui Chu, and Dr. Ching-Mao Huang for their assistance with TEM and EDX measurements.

Graphical Abstract

Cut here to cure: Doxorubicin attached to pH-sensitive mesoporous silica nanoparticles (MSN-hydrazone-Dox) shows potential in the chemotherapeutic treatment of liver cancer. Hydrolysis of the pH-sensitive hydrazone bond in the acidic environment of endosomes/lysosomes (see picture) releases Dox intracellularly from the MSN nanochannels, resulting in highly efficient apoptotic cell death.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.